Transforming growth factor beta and the liver - PubMed (original) (raw)

Review

Transforming growth factor beta and the liver

D M Bissell et al. Hepatology. 2001 Nov.

No abstract available

PubMed Disclaimer

Similar articles

• [Smad 7 and post-receptor signal regulation of transforming growth factor-beta1].
  Wu JX, Meng XJ, Chen YW, Cheng JL, Li DG, Lu HM. Wu JX, et al. Zhonghua Gan Zang Bing Za Zhi. 2003 May;11(5):315-7. Zhonghua Gan Zang Bing Za Zhi. 2003. PMID: 12773256 Review. Chinese. No abstract available.
• Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
  Senturk S, Mumcuoglu M, Gursoy-Yuzugullu O, Cingoz B, Akcali KC, Ozturk M. Senturk S, et al. Hepatology. 2010 Sep;52(3):966-74. doi: 10.1002/hep.23769. Hepatology. 2010. PMID: 20583212
• Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
  Park YN, Chae KJ, Oh BK, Choi J, Choi KS, Park C. Park YN, et al. Hepatogastroenterology. 2004 Mar-Apr;51(56):396-400. Hepatogastroenterology. 2004. PMID: 15086168
• The rationale for targeting TGF-β in chronic liver diseases.
  Giannelli G, Mikulits W, Dooley S, Fabregat I, Moustakas A, ten Dijke P, Portincasa P, Winter P, Janssen R, Leporatti S, Herrera B, Sanchez A. Giannelli G, et al. Eur J Clin Invest. 2016 Apr;46(4):349-61. doi: 10.1111/eci.12596. Epub 2016 Mar 12. Eur J Clin Invest. 2016. PMID: 26823073 Review.
• Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells.
  Herzer K, Ganten TM, Schulze-Bergkamen H, Grosse-Wilde A, Koschny R, Krammer PH, Walczak H. Herzer K, et al. Hepatology. 2005 Jul;42(1):183-92. doi: 10.1002/hep.20757. Hepatology. 2005. PMID: 15962328

Cited by

• Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy.
  Habib S. Habib S. World J Gastrointest Pathophysiol. 2024 Aug 22;15(4):93606. doi: 10.4291/wjgp.v15.i4.93606. World J Gastrointest Pathophysiol. 2024. PMID: 39220834 Free PMC article. Review.
• Lactucin reverses liver fibrosis by inhibiting TGF-β1/STAT3 signaling pathway and regulating short-chain fatty acids metabolism.
  Qin D, Han C, Gao Y, Li H, Zhu L. Qin D, et al. Sci Rep. 2024 Aug 20;14(1):19323. doi: 10.1038/s41598-024-70253-5. Sci Rep. 2024. PMID: 39164375 Free PMC article.
• Exploring the roles of non-coding RNAs in liver regeneration.
  Li P, Ma X, Huang D, Gu X. Li P, et al. Noncoding RNA Res. 2024 Apr 16;9(3):945-953. doi: 10.1016/j.ncrna.2024.04.003. eCollection 2024 Sep. Noncoding RNA Res. 2024. PMID: 38680418 Free PMC article. Review.
• Pleiotropic Action of TGF-Beta in Physiological and Pathological Liver Conditions.
  Braczkowski MJ, Kufel KM, Kulińska J, Czyż DŁ, Dittmann A, Wiertelak M, Młodzik MS, Braczkowski R, Soszyński D. Braczkowski MJ, et al. Biomedicines. 2024 Apr 22;12(4):925. doi: 10.3390/biomedicines12040925. Biomedicines. 2024. PMID: 38672279 Free PMC article. Review.
• DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling.
  Liu QQ, Chen J, Ma T, Huang W, Lu CH. Liu QQ, et al. Sci Rep. 2024 Apr 24;14(1):9425. doi: 10.1038/s41598-024-59698-w. Sci Rep. 2024. PMID: 38658618 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.
  • Wiley